Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
29.33
-0.66 (-2.20%)
Oct 29, 2026, 11:15 AM EDT - Market open
Xencor Employees
Xencor had 260 employees as of December 31, 2025. The number of employees increased by 10 or 4.00% compared to the previous year. That makes Xencor the 24,908th largest employer in the world and 3,192nd in the United States.
Employees
260
Change (1Y)
10
Growth (1Y)
4.00%
Revenue / Employee
$403,742
Profits / Employee
-$628,173
Market Cap
2.18B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 260 | 10 | 4.00% | 260 | 0 |
| Dec 31, 2024 | 250 | -30 | -10.71% | 250 | 0 |
| Dec 31, 2023 | 280 | -1 | -0.36% | 280 | 0 |
| Dec 31, 2022 | 281 | 27 | 10.63% | 281 | 0 |
| Dec 31, 2021 | 254 | 52 | 25.74% | 254 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Agios Pharmaceuticals | 540 |
| Maravai LifeSciences Holdings | 415 |
| Vera Therapeutics | 361 |
| Harmony Biosciences Holdings | 293 |
| Immunome | 247 |
| Celldex Therapeutics | 198 |
| Precigen | 160 |
XNCR News
- 2 days ago - Xencor price target raised to $43 from $20 at RBC Capital - TheFly
- 2 days ago - Xencor price target raised to $40 from $29 at Truist - TheFly
- 2 days ago - Xencor price target raised to $40 from $29 at Truist - TheFly
- 2 days ago - Xencor price target raised to $45 from $30 at Wedbush - TheFly
- 2 days ago - Xencor price target raised to $45 from $35 at Barclays - TheFly
- 3 days ago - Xencor Transcript: Study update - Transcripts
- 3 days ago - Xencor Press release: Study update - Filings
- 3 days ago - Xencor Slides: Study update - Filings